AVITA Medical (RCEL) EBIT Growth (1y) (2019 - 2026)
AVITA Medical (RCEL) EBIT Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 16.18% |
| 10 | AVITA Medical | 308.73 Mn | 297.59 Mn | 17.77 Mn | 38.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.51% |
| Dec 31, 2025 | -4.53% |
| Sep 30, 2025 | 33.70% |
| Jun 30, 2025 | 28.65% |
| Mar 31, 2025 | 31.26% |
| Dec 31, 2024 | 18.87% |
| Sep 30, 2024 | -48.36% |
| Jun 30, 2024 | -39.94% |
| Mar 31, 2024 | -73.61% |
| Dec 31, 2023 | -23.97% |
| Sep 30, 2023 | -61.90% |
| Mar 31, 2023 | -4.47% |
| Sep 30, 2022 | 65.47% |
| Mar 31, 2022 | -58.35% |
| Sep 30, 2021 | -62.95% |
| Jun 30, 2021 | 17.88% |
| Mar 31, 2021 | 61.11% |
| Dec 31, 2020 | 46.84% |
| Sep 30, 2020 | -179.22% |
| Jun 30, 2020 | -73.85% |